ReleaseWire

NASDAQ:TLIS Long Term Investor Alert: Investigation of Potential Wrongdoing at Talis Biomedical Corporation

An investigation on behalf of current long term investors in Talis Biomedical Corporation (NASDAQ:TLIS) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

Posted: Tuesday, May 10, 2022 at 11:00 AM CDT

San Diego, CA -- (SBWire) -- 05/10/2022 --Certain directors of Talis Biomedical Corporation are under investigation over potential breaches of fiduciary duties.

Investors who are current long term investors in Talis Biomedical Corporation (NASDAQ: TLIS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NASDAQ: TLIS stocks follows a lawsuit filed against Talis Biomedical Corporation over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: TLIS stocks, concerns whether certain Talis Biomedical directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that the Defendants failed to disclose to investors: (1) that the comparator assay in the primary study lacked sufficient sensitivity to support Talis's EUA application for Talis One COVID-19 test; (2) that, as a result, Talis was reasonably likely to experience delays in obtaining regulatory approval for the Talis One COVID-19 test; (3) that, as a result, the Company's commercialization timeline would be significantly delayed; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.